(4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

Basic Information

View in Editor

CAS Number

39026-92-1

Molecular Formula

C21H18N2O5

Molecular Weight

378.38 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

Yellow powder

Melting Point

223-225 ºC

SMILES

View in Editor

CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)OC)O

InChI

InChI=1S/C21H18N2O5/c1-3-21(26)14-8-16-18-11(7-12-15(22-18)5-4-6-17(12)27-2)9-23(16)19(24)13(14)10-28-20(21)25/h4-8,26H,3,9-10H2,1-2H3/t21-/m0/s1

InChIKey

XVMZDZFTCKLZTF-NRFANRHFSA-N

LogP

2.0882

Topological Polar Surface Area

90.65 Å²

Hydrogen Bond Donor/Acceptor

1 / 7

Complexity

790

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

9-Methoxycamptothecin
9-Methoxycamptothecine
10-methoxycamptothecin
9-methoxycamtothecin
Camptothecin,9-methoxy
Camptothecin, 9-methoxy-
NSC176323
XVMZDZFTCKLZTF-NRFANRHFSA-N
8044AH
NCI60_001450
N2593
C21H18N2O5
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-, 4-ethyl-4-hydroxy-10-methoxy-, (S)-
NSC-176323
(4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
ZB1864
F17695
9-Methoxycamptothecine,9-Methoxycamptothecin,NSC 176323

MDL Number

MFCD03840473

FAQ

What regulatory guidelines apply to (4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (CAS: 39026-92-1)?

This compound falls under several regulatory guidelines, including GHS for hazardous chemicals, REACH for EU chemical regulations, and FDA/EPA requirements for pharmaceutical and environmental safety. Manufacturers must comply with these regulations for labeling, storage, and disposal.

Are there alternatives to (4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione in synthesis?

There are several alternatives such as isomers, analogs like 4-hydroxy-10-methoxyindolizino[1,2-b]quinoline, and substitute reagents like ethyl 4-hydroxy-10-methoxyindolizino[1,2-b]quinoline-3-carboxylate. These can be used based on specific synthetic requirements and availability.

What is the market or research trend for (4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (CAS: 39026-92-1)?

The compound is gaining attention in research for its potential applications in pharmaceuticals and materials science. Market trends indicate increasing interest in its synthetic analogs and derivatives, driven by growing demand in niche pharmaceutical and chemical industries.

How should waste containing (4S)-4-Ethyl-4-hydroxy-10-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (CAS: 39026-92-1) be handled?

Waste containing the compound should be collected in appropriate containers and disposed of through incineration or professional waste disposal services. Environmental protection measures include proper containment to prevent leaks and disposal in accordance with local hazardous waste regulations.